A Population Pharmacokinetic Modeling and Simulation Study of Posaconazole Oral Suspension in Immunocompromised Pediatric Patients: A Short Communication-Reference-Cited by-同舟云学术

A Population Pharmacokinetic Modeling and Simulation Study of Posaconazole Oral Suspension in Immunocompromised Pediatric Patients: A Short Communication

Published:2021-08 Issue:4 Volume:43 Page:512-518
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Elkayal Omar,Spriet Isabel,Uyttebroeck Anne,Colita Anca,Annaert Pieter,Allegaert Karel,Smits Anne,Van Daele Ruth,Dreesen Erwin

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference38 articles.

1. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia;Cornely;N Engl J Med.,2007

2. Pharmacokinetic/pharmacodynamic profile of posaconazole;Li;Clin Pharmacokinet.,2010

3. Long-term posaconazole treatment and follow-up of rhino-orbital-cerebral mucormycosis in a diabetic girl;Tarani;Pediatr Diabetes,2009

4. Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology;Ashbee;J Antimicrob Chemother.,2014

5. Factors influencing the pharmacokinetics of prophylactic posaconazole oral suspension in patients with acute myeloid leukemia or myelodysplastic syndrome;Vehreschild;Eur J Clin Pharmacol.,2012

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Individualized regimen of Posaconazole oral suspension in Chinese HSCT patients based on population pharmacokinetic model;Scientific Reports;2024-08-31

2. Dosing of IV posaconazole to treat critically ill patients with invasive pulmonary aspergillosis: a population pharmacokinetics modelling and simulation study;Journal of Antimicrobial Chemotherapy;2024-06-03

3. Posaconazole in paediatric malignancy and haematopoietic stem cell transplant: dosing to achieve therapeutic concentration;Journal of Antimicrobial Chemotherapy;2024-04-18

4. The Dosage Recommendation of Cyclosporin in Children with Hemophagocytic Lymphohistiocytosis based on Population Pharmacokinetic Model;Current Pharmaceutical Design;2023-10

5. Population Pharmacokinetics of Posaconazole in Immune-Compromised Children and Assessment of Target Attainment in Invasive Fungal Disease;Clinical Pharmacokinetics;2023-05-14